XML 62 R51.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-based compensation - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2022
Mar. 31, 2021
[1]
Dec. 31, 2021
Number of Shares Underlying Outstanding Options      
Number of shares underlying outstanding options, beginning balance (in shares) 24,129,096    
Number of shares underlying outstanding options, options exercised (in shares) (797,380) (727,114)  
Number of shares underlying outstanding options, options cancelled (in shares) (77,753)    
Number of shares underlying outstanding options, ending balance (in shares) 23,253,963   24,129,096
Number of shares underlying outstanding options, vested and expected to vest (in shares) 23,253,963    
Number of shares underlying outstanding options, exercisable (in shares) 9,954,974    
Weighted- Average Exercise Price per Share      
Weighted average exercise price, beginning balance (in dollars per share) $ 1.01    
Weighted average exercise price, options exercised (in dollars per share) 0.20    
Weighted average exercise price, options cancelled (in dollars per share) 4.21    
Weighted average exercise price, ending balance (in dollars per share) 1.03   $ 1.01
Weighted average exercise price, options vested and expected to vest (in dollars per share) 1.03    
Weighted average exercise price, options exercisable (in dollars per share) $ 0.80    
Weighted- Average Remaining Contractual Term (in years)      
Stock options outstanding, weighted average remaining contractual term 8 years 3 months 18 days   8 years 7 months 6 days
Stock options exercised, weighted average remaining contractual term    
Stock options vested and expected to vest, weighted average remaining contractual term 8 years 3 months 18 days    
Stock options exercisable, weighted average remaining contractual term 8 years 1 month 6 days    
Aggregate Intrinsic Value      
Stock options outstanding, aggregate intrinsic value, beginning balance $ 100,992    
Stock options exercised, aggregate intrinsic value    
Stock options outstanding, aggregate intrinsic value, ending balance 84,888   $ 100,992
Stock options vested and expected to vest, aggregate intrinsic value 84,888    
Stock options exercisable, aggregate intrinsic value $ 37,186    
[1] The shares of the Company’s common and redeemable convertible preferred stock, prior to the Merger (as defined in Note 1), have been retroactively restated as shares reflecting the exchange ratio of approximately 0.703 established in the Merger as described in Note 1.